These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 9516930
21. Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood. de Vries TJ, Fourkour A, Punt CJ, Diepstra H, Ruiter DJ, van Muijen GN. Br J Cancer; 1999 Nov; 81(6):1066-70. PubMed ID: 10576666 [Abstract] [Full Text] [Related]
22. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Ghossein RA, Coit D, Brennan M, Zhang ZF, Wang Y, Bhattacharya S, Houghton A, Rosai J. Clin Cancer Res; 1998 Feb; 4(2):419-28. PubMed ID: 9516931 [Abstract] [Full Text] [Related]
31. Quantitation of GD2 synthase mRNA by real-time reverse transcription-polymerase chain reaction: utility in bone marrow purging of neuroblastoma by anti-GD2 antibody 3F8. Cheung IY, Lo Piccolo MS, Collins N, Kushner BH, Cheung NK. Cancer; 2002 Jun 01; 94(11):3042-8. PubMed ID: 12115395 [Abstract] [Full Text] [Related]
32. NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma. Goydos JS, Patel M, Shih W. J Surg Res; 2001 Jun 15; 98(2):76-80. PubMed ID: 11397121 [Abstract] [Full Text] [Related]
33. The use of real-time reverse transcription-PCR for prostate-specific antigen mRNA to discriminate between blood samples from healthy volunteers and from patients with metastatic prostate cancer. Patel K, Whelan PJ, Prescott S, Brownhill SC, Johnston CF, Selby PJ, Burchill SA. Clin Cancer Res; 2004 Nov 15; 10(22):7511-9. PubMed ID: 15569981 [Abstract] [Full Text] [Related]
34. Detection of tyrosinase mRNA by an optimised nested RT-PCR in the peripheral blood of patients with advanced malignant melanoma. Glumac N, Hocevar M, Snoj M, Novakovic S. J Exp Clin Cancer Res; 2001 Dec 15; 20(4):529-36. PubMed ID: 11876547 [Abstract] [Full Text] [Related]
35. Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes. Calogero A, Timmer-Bosscha H, Schraffordt Koops H, Tiebosch AT, Mulder NH, Hospers GA. Br J Cancer; 2000 Jul 15; 83(2):184-7. PubMed ID: 10901368 [Abstract] [Full Text] [Related]
36. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. Marchetti A, Buttitta F, Bertacca G, Zavaglia K, Bevilacqua G, Angelucci D, Viacava P, Naccarato A, Bonadio A, Barassi F, Felicioni L, Salvatore S, Mucilli F. J Pathol; 2001 Sep 15; 195(2):186-90. PubMed ID: 11592097 [Abstract] [Full Text] [Related]
37. Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction. Lewis TB, Robison JE, Bastien R, Milash B, Boucher K, Samlowski WE, Leachman SA, Dirk Noyes R, Wittwer CT, Perreard L, Bernard PS. Cancer; 2005 Oct 15; 104(8):1678-86. PubMed ID: 16116595 [Abstract] [Full Text] [Related]
38. Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma. Helfrich I, Edler L, Sucker A, Thomas M, Christian S, Schadendorf D, Augustin HG. Clin Cancer Res; 2009 Feb 15; 15(4):1384-92. PubMed ID: 19228739 [Abstract] [Full Text] [Related]